BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28168372)

  • 1. High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.
    Godi C; De Vita E; Tombetti E; Davagnanam I; Haddow L; Jäger HR
    Eur Radiol; 2017 Sep; 27(9):3593-3599. PubMed ID: 28168372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy.
    Cosottini M; Tavarelli C; Del Bono L; Doria G; Giannelli M; De Cori S; Michelassi MC; Bartolozzi C; Murri L
    Eur Radiol; 2008 May; 18(5):1024-30. PubMed ID: 18324406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.
    Thurnher MM; Boban J; Rieger A; Gelpi E
    AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High b-value diffusion-weighted MR imaging of normal brain at 3T.
    Cihangiroglu M; Uluğ AM; Firat Z; Bayram A; Kovanlikaya A; Kovanlikaya I
    Eur J Radiol; 2009 Mar; 69(3):454-8. PubMed ID: 18162352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations.
    Bergui M; Bradac GB; Oguz KK; Boghi A; Geda C; Gatti G; Schiffer D
    Neuroradiology; 2004 Jan; 46(1):22-5. PubMed ID: 14593446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up.
    da Pozzo S; Manara R; Tonello S; Carollo C
    Radiol Med; 2006 Oct; 111(7):971-7. PubMed ID: 17021685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
    Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
    Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-signal-intensity rim on susceptibility-weighted imaging is not a specific finding to progressive multifocal leukoencephalopathy.
    Umino M; Maeda M; Ii Y; Tomimoto H; Sakuma H
    J Neurol Sci; 2016 Mar; 362():155-9. PubMed ID: 26944139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging at b1000 for identifying intracerebral hemorrhage: preliminary sensitivity, specificity, and inter-rater variability.
    Keigler G; Goldberg I; Eichel R; Gomori JM; Cohen JE; Leker RR
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1934-8. PubMed ID: 24795096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
    Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
    Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.
    Mader I; Herrlinger U; Klose U; Schmidt F; Küker W
    Neuroradiology; 2003 Oct; 45(10):717-21. PubMed ID: 12942223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
    Alleg M; Solis M; Baloglu S; Cotton F; Kerschen P; Bourre B; Ahle G; Pruvo JP; Leclerc X; Vermersch P; Papeix C; Maillart É; Houillier C; Chabrot CM; Claise B; Malak S; Martin-Blondel G; Bonneville F; Caulier A; Marolleau JP; Bonnefoy JT; Agape P; Kennel C; Roussel X; Chauchet A; De Seze J; Fafi-Kremer S; Kremer S
    Eur Radiol; 2021 May; 31(5):2944-2955. PubMed ID: 33155106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.
    Miyagawa M; Maeda M; Umino M; Kagawa K; Nakamichi K; Sakuma H; Tomimoto H
    J Neurol Sci; 2014 Sep; 344(1-2):198-202. PubMed ID: 24972818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging.
    Ernst T; Chang L; Witt M; Walot I; Aronow H; Leonido-Yee M; Singer E
    Radiology; 1999 Feb; 210(2):539-43. PubMed ID: 10207441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffusion-weighted MR imaging characterization of progressive multifocal leucoencefalopathy (PML) lesions].
    Barata Tavares J; Geraldo AF; Neto L; Reimão S; Campos JG
    Acta Med Port; 2012; 25 Suppl 1():34-7. PubMed ID: 23177580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: a case report.
    Port JD; Miseljic S; Lee RR; Ali SZ; Nicol TL; Royal W; Chin BB
    Neuroradiology; 1999 Dec; 41(12):895-8. PubMed ID: 10639663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.
    Buckle C; Castillo M
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1031-5. PubMed ID: 20360338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation.
    Lima MA; Hanto DW; Curry MP; Wong MT; Dang X; Koralnik IJ
    J Neurovirol; 2005 Feb; 11(1):46-50. PubMed ID: 15804958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas.
    Wang X; Shu X; He P; Cai Y; Geng Y; Hu X; Sun Y; Xiao H; Zheng W; Song Y; Xue Y; Jiang R
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38528135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.
    Carra-Dalliere C; Menjot de Champfleur N; Deverdun J; Ayrignac X; Nerrant E; Makinson A; Casanova ML; Labauge P
    J Neuroradiol; 2016 Feb; 43(1):6-10. PubMed ID: 26475668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.